Aiken, A., Lam, T., Gilmore, W., Burns, L., Chikritzhs, T.N., Lenton, S., Lloyd, B., Lubman, D., Ogeil, R. and Allsop, S. (2018). Youth perceptions of alcohol advertising: Are current advertising regulations working? Australian and New Zealand Journal of Public Health. DOI: http://dx.doi.org/10.1111/1753-6405.12792
Aldridge J, Stevens A, Barratt MJ. (2018). Harms, Benefits and the Policing of Cryptomarkets: A Response to Commentaries. Addictions, 113, 802-804. doi: 10.1111/add.14134
Batterham PJ, Calear AL, Carragher N, Sunderland M. (2018). Prevalence and predictors of distress associated with completion of an online survey assessing mental health and suicidality in the community. Psychiatry Research, 262, 348-350. doi: 10.1016/j.psychres.2017.08.048
Benfer I, Zahnow R, Barratt MJ, Maier L, Winstock A, Ferris J. (2018). The impact of drug policy liberalisation on willingness to seek help for problem drug use: A comparison of 20 countries. International Journal of Drug Policy. doi: 10.1016/j.drugpo.2018.03.032
Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, Rich J. (2018). Erratum to: A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug and Alcohol Dependence, 186, 9. doi: 10.1016/j.drugalcdep.2018.02.005
Burns, S., Maycock, B., Hildebrand, J., Zhao, Y., Allsop, S., Lobo, R. and Howat, P.A. (2018). Development and testing of the Youth Alcohol Norms Survey (YANS) instrument to measure youth alcohol norms and psychosocial influences. BMJ Open, 8, (5), pp. e019641. DOI: http://dx.doi.org/10.1136/bmjopen-2017-019641
Cameron, J., Pidd, K., Roche, A., Lee, N., & Jenner, L. (2018). A co-produced cultural approach to workplace alcohol interventions: barriers and facilitators. Drugs: Education, Prevention and Policy, 1-11. doi:10.1080/09687637.2018.1468871
Chervonsky E, Hunt C. (2018). Emotion Regulation, Mental Health, and Social Wellbeing in a Young Adolescent Sample: A Concurrent and Longitudinal Investigation. Emotion. doi: 10.1037/emo0000432
Chronister, K.J., Lintzeris, N., Jackson, A., Ivan, M., Dietze, P., Lenton, S., Kearley, J. and van Beek, I. (2018). Findings and lessons learnt from implementing Australia’s first health service based take-home naloxone program. Drug and Alcohol Review, 37, (4), pp. 464-471. DOI: http://dx.doi.org/10.1111/dar.12400
Connor J, Hall W. (2018). Thresholds for safer alcohol use might need lowering. The Lancet, 391, 1460-1461. doi: 10.1016/S0140-6736(18)30545-2
Dietze, P., Stare, M., Cogger, S., Nambiar, D., Olsen, A., Burns, L. and Lenton, S. (2018). Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia: Variations across capital cities. Drug and Alcohol Review, 37, (4), pp. 457-463. DOI: http://dx.doi.org/10.1111/dar.12644
Dwyer, R., Olsen, A., Fowlie, C., Gough, C., van Beek, I., Jauncey, M., Lintzeris, N., Oh, G., Dicka, J., Fry, C., Hayllar, J. and Lenton, S. (2018). An overview of take-home naloxone programs in Australia. Drug and Alcohol Review, 37, (4), pp. 440-449. DOI: http://dx.doi.org/10.1111/dar.12812
Eastwood B, Peacock A, Millar T, Jones A, Knight J, Horgan P, Lowden T, Willey P, Marsden J. (2018). Effectiveness of inpatient withdrawal and residential rehabilitation interventions for alcohol use disorder: A national observational, cohort study in England. Journal of Substance Abuse Treatment, 88, 8. doi: 10.1016/j.jsat.2018.02.001
Ezard N, Cecilio ME, Clifford B, Baldry E, Burns L, Day CA, Shanahan M, Dolan K. (2018). A managed alcohol program in Sydney, Australia: Acceptability, cost-savings and non-beverage alcohol use. Drug and Alcohol Review, 37, S184-S194. doi: 10.1111/dar.12702
Ezard N, Webb B, Clifford B, Cecilio ME, Jellie A, Lea T, Rodgers C, Ruth S, Bruno R. (2018). Substance Use and Sex Index (SUSI): First stage development of an assessment tool to measure behaviour change in sexualised drug use for substance use treatment studies. International Journal of Drug Policy. doi: 10.1016/j.drugpo.2018.03.020
Hall W, Kozlowski LT. (2018). The diverging trajectories of cannabis and tobacco policies in the United States: reasons and possible implications. Addiction, 113, 595-601. doi: 10.1111/add.13845
Hattingh, L. and Tait, R.J. (2018). Pharmacy-based alcohol misuse services: current perspectives. Integrated Pharmacy Research and Practice, 7, pp. 21-31. DOI: http://dx.doi.org/10.2147/IPRP.S140431
Howard, K.A., Griffiths, K.M., McKetin, R. and Ma, J. (2018). Can a brief biologically-based psychoeducational intervention reduce stigma and increase help-seeking intentions for depression in young people? A randomised controlled trial. Journal of Child & Adolescent Mental Health. DOI: http://dx.doi.org/10.2989/17280583.2018.1467323
Hughes CE, Barratt MJ, Ferris JA, Maier LJ, Winstock AR. (2018). Drug-related police encounters across the globe: How do they compare? International Journal of Drug Policy. doi: 10.1016/j.drugpo.2018.03.005
Jones HE, Goulding N, Hickman M. (2018). Commentary on Lai et al. (2018): Potential and limitations of wastewater-based epidemiology in monitoring substance use. Addiction, 113, 1137-1138. doi: 10.1111/add.14207
Knight A, Maple M, Shakeshaft A, Shakehsaft B, Pearce T. (2018). Improving the evidence base for services working with youth at-risk of involvement in the criminal justice system: developing a standardised program approach. Health and Justice, 6. doi: 10.1186/s40352-018-0066-5
Kovess-Masfety V, Saha S, Lim CCW, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Borges G, de Girolamo G, de Jonge P, Demyttenaere K, Florescu S, Haro JM, Hu C, Karam EG, Kawakami N, Lee S, Lepine JP, Navarro-Mateu F, Stagnaro JC, ten Have M, Viana MC, Kessler RC, McGrath JJ, Al-Kaisy S, Andrade H, Benjet C, Bruffaerts R, Bunting B, de A, Cardoso G, Chatterji S, Cia AH, Degenhardt L, Fayyad J, Gureje O, He Y, Hinkov H, Hu CY, Huang Y, Karam N, Kiejna A, Levinson D, Medina-Mora E, Mneimneh Z, Moskalewicz J, Pennell BE, Piazza M, Posada-Villa J, Scott KM, Slade T, Stein DJ, Torres Y, Whiteford H, Williams DR, Wojtyniak B. (2018). Psychotic experiences and religiosity: data from the WHO World Mental Health Surveys. Acta Psychiatrica Scandinavica, 137, 306-315. doi: 10.1111/acps.12859
Lappin JM, Darke S, Farrell M. (2018). Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implications. Drug and Alcohol Dependence, 187, 134-140. doi: 10.1016/j.drugalcdep.2018.02.032
Ma J, Li XD, Wang TY, Li SX, Meng SQ, Blow FC, Ilgen M, Degenhardt L, Lappin J, Wu P, Shi J, Bao YP, Lu L. (2018). Relationship between the duration of methamphetamine use and psychotic symptoms: A two-year prospective cohort study. Drug and Alcohol Dependence, 187, 363-369. doi: 10.1016/j.drugalcdep.2018.03.023
Ma J, Sun XJ, Wang RJ, Wang TY, Su MF, Liu MX, Li SX, Han Y, Meng SQ, Wu P, Shi J, Bao YP, Lu L. (2018). Profile of psychiatric symptoms in methamphetamine users in China: Greater risk of psychiatric symptoms with a longer duration of use. Psychiatry Research, 262, 184-192. doi: 10.1016/j.psychres.2018.02.017
McCormack C, Hutchinson D, Burns L, Youssef G, Wilson J, Elliott E, Allsop S, Najman J, Jacobs S, Rossen L, Olsson C, Mattick R. (2018). Maternal and partner prenatal alcohol use and infant cognitive development. Drug and Alcohol Dependence, 185, 330-338. doi: 10.1016/j.drugalcdep.2017.12.038
McKetin, R. (2018). Methamphetamine psychosis: insights from the past. Addiction. DOI: http://dx.doi.org/10.1111/add.14170
McKetin, R., Lubman, D., Baker, A., Dawe, S., Ross, J., Mattick, R. and Degenhardt, L. (2018). The relationship between methamphetamine use and heterosexual behaviour: evidence from a prospective longitudinal study. Addiction. DOI: http://dx.doi.org/10.1111/add.14181
McKetin, R. (2017). Why methamphetamine-related deaths need more attention. Addiction, 112, pp. 2203-2204. DOI: https://doi.org/10.1111/add.14021
Mills KL, Marel C, Darke S, Ross J, Slade T, Teesson M. (2018). The long-term impact of post traumatic stress disorder on recovery from heroin dependence. Journal of Substance Abuse Treatment, 89, 60-66. doi: 10.1016/j.jsat.2018.04.001
Murray CJL, Mokdad AH, Ballestros K, Echko M, Glenn S, Olsen HE, Mullany E, Lee A, Khan AR, Ahmadi A, Ferrari AJ, Kasaeian A, Werdecker A, Carter A, Zipkin B, Sartorius B, Serdar B, Sykes BL, Troeger C, Fitzmaurice C, Rehm CD, Santomauro D, Kim D, Colombara D, Schwebel DC, Tsoi D, Kolte D, Nsoesie E, Nichols E, Oren E, Charlson FJ, Patton GC, Roth GA, Dean Hosgood H, Whiteford HA, Kyu H, Erskine HE, Huang H, Martopullo I, Singh JA, Nachega JB, Sanabria JR, Abbas K, Ong K, Tabb K, Krohn KJ, Cornaby L, Degenhardt L, Moses M, Farvid M, Griswold M, Criqui M, Bell M, Nguyen M, Wallin M, Mirarefin M, Qorbani M, Younis M, Fullman N, Liu P, Briant P, Gona P, Havmoller R, Leung R, Kimokoti R, Bazargan-Hejazi S, Hay SI, Yadgir S, Biryukov S, Vollset SE, Alam T. (2018). The state of US health, 1990-2016: Burden of diseases, injuries, and risk factors among US states. JAMA - Journal of the American Medical Association, 319, 1444-1472. doi: 10.1001/jama.2018.0158
Olsen, A., Dwyer, R. and Lenton, S. (2018). Editorial: Take-home naloxone in Australia and beyond. Drug and Alcohol Review, 37, (4), pp. 437-439. DOI: http://dx.doi.org/10.1111/dar.12700
Olsen, A., McDonald, D., Lenton, S. and Dietze, P. (2018). Assessing causality in drug policy analyses: How useful are the Bradford Hill criteria in analyzing take-home naloxone programs? Drug and Alcohol Review, 37, (4), pp. 499-501. DOI: http://dx.doi.org/10.1111/dar.12523
Peacock A, Eastwood B, Jones A, Millar T, Horgan P, Knight J, Randhawa K, White M, Marsden J. (2018). Effectiveness of community psychosocial and pharmacological treatments for alcohol use disorder: A national observational cohort study in England. Drug and Alcohol Dependence, 186, 60-67. doi: 10.1016/j.drugalcdep.2018.01.019
Peacock A, Larance B, Farrell M, Cairns R, Buckley N, Degenhardt L. (2018). Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol. BMJ Open, 8. doi: 10.1136/bmjopen-2017-020006
Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, Giovino GA, West R, Hall W, Griffiths P, Ali R, Gowing L, Marsden J, Ferrari AJ, Grebely J, Farrell M, Degenhardt L. (2018). Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. doi: 10.1111/add.14234
Ritter A, Hughes CE, Lancaster K, Hoppe R. (2018). Using the Advocacy Coalition Framework and Multiple Streams policy theories to examine the role of evidence, research and other types of knowledge in drug policy. Addiction. doi: 10.1111/add.14197
Ritter A, Lancaster K, Diprose R. (2018). Improving drug policy: The potential of broader democratic participation. International Journal of Drug Policy, 55, 1-7.doi: 10.1016/j.drugpo.2018.01.016
Roxburgh A, Pilgrim JL, Hall WD, Burns L, Degenhardt L. (2018). Accurate identification of opioid overdose deaths using coronial data. Forensic Science International, 287, 40-46. doi: 10.1016/j.forsciint.2018.03.032
Simmons R, Ireland G, Irving W, Hickman M, Sabin C, Ijaz S, Ramsay M, Lattimore S, Mandal S. (2018). Establishing the cascade of care for hepatitis C in England—benchmarking to monitor impact of direct acting antivirals. Journal of Viral Hepatitis, 25, 482-490. doi: 10.1111/jvh.12844
Thornton LK, Chapman C, Leidl D, Conroy C, Teesson M, Slade T, Koning I, Champion K, Stapinski L, Newton N. (2018). Climate schools plus: An online, combined student and parent, universal drug prevention program. Internet Interventions, 12, 36-45. doi: 10.1016/j.invent.2018.03.007
Treeby MS, Rice SM, Cocker F, Peacock A, Bruno R. (2018). Guilt-proneness is associated with the use of protective behavioral strategies during episodes of alcohol use. Addictive Behaviors, 79, 120-123. doi: 10.1016/j.addbeh.2017.12.027
Van de Ven K, Mulrooney KJD. (2018). Are doping tests for the high school and recreational athletes worth it? In Newton DE (Ed.). Steroids and Doping in Sports: A Reference Handbook.Santa Barbara, California: ABC-CLIO.
Voce, A., McKetin, R., Burns, R.A., Castle, D. and Calabria, B. (2018). The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses. Psychiatry Research. DOI: http://dx.doi.org/10.1016/j.psychres.2018.04.015
Vuong T, Ritter A, Shanahan M, Ali R, Nguyen N, Pham K, Vuong TTA, Le GM. (2018). Outcomes of compulsory detention compared to community-based voluntary methadone maintenance treatment in Vietnam. Journal of Substance Abuse Treatment, 87, 9-15. doi: 10.1016/j.jsat.2018.01.011